REPRESENTATIVE EXPERIENCE
Kate Chen
Health Care and Life Sciences
Advised a HK-listed international pharmaceutical company on its commercialization and distribution of products in global markets.
Advised MSD, the animal health division of Merck, on the acquisition of a manufacturing facility in China.
Advised Novartis on its transaction to enlist Chinese manufacturer Cellular Biomedicine (CBMG) to make its cutting-edge infant leukaemia gene-modifying cancer treatment Kymriah available in China.
Advised Cardinal Health on the joint venture with a Chinese vascular intervention medical device developer and the e-commerce operation and regulatory issues related to its China subsidiary.
Advised one of the world's largest healthcare company on its proposed acquisition of a U.S.-based health care group.
Advised Navis Capital Partners on the acquisition of a Singapore-based wellness business company.
FDI & General Corporate
Advised a manufacturer of optical communication components and subsystems on general corporate and regulatory issues on its operations in China.
Advised a leading supplier of precast concrete technology on the establishment of a joint venture with a Chinese manufacturer of construction equipment.
Advised a world leading cochlear implant producer on setting up a joint venture manufacturing factory in China.
Advised a Singapore-based home care service provider on its investment in eight nursing stations in Shanghai.
Advised Discover Financial on general corporate and regulatory issues on its subsidiaries in China.
Advised a U.S.-based leading manufacturer of energy-saving light in setting up a wholly foreign-owned enterprise in Shanghai.
Advised a leading water solutions provider on establishing a joint venture with a Chinese party in Xi’an.
Advised numerous prestigious U.S. universities on general corporate and regulatory issues in China.
Advised a world-renowned music college on its cooperation with a Chinese entertainment company to build a music centre in Shenzhen.
Advised a UK-based global reinsurance broker on general regulatory and corporate issues of its Shanghai insurance brokerage joint venture, and its merger with another reinsurance giant valued at about $30 billion.
Advised a Spanish fashion brand on commercialization of its branded products in China.
Advised a multinational equipment manufacturer on general corporate and regulatory issues on its multiple subsidiaries in China.
Advised a leading global professional services firm on the corporate and operational restructuring of its Asia Pacific businesses, as part of a major worldwide restructuring exercise.
Advised a German air cleaning system manufacturing group on its global restructuring.
Advised a leading diversified metal solutions provider on dissolution of its manufacturing subsidiary in Shanghai.
Labor, Employment, And Workplace Safety
Advised numerous prestigious U.S. universities on employment issues regarding its daily operations and various education cooperation programs with Chinese universities in China.
Advised a U.S. leading health care diagnostics corporation on a wide range of day-to-day employment-related matters.
Advised a high-end jewellery manufacturer and retailer on employment issues regarding its multiple subsidiaries in China and labor disputes.
Advised an Australian dairy company on various employment issues, including termination of senior management in China.
Advised a leading global professional services firm on non-compete issues of partners in China.
Advised one of the world’s largest online travel platform on its restructuring and redundancies plan in China.
Advised a U.S.-listed clothing company regarding the employee stock ownership plan in China.
Food and Beverage
Advised an Australian dairy company on the establishment of its trading company in China and various employment issues, including termination of senior management in China.
Advised Central American Bottling Corporation regarding the commercialization and distribution of beverage in China.
Advised an alcohol manufacturer on its transfer pricing audit and tax issues related to the secondary sale.
Tax
Advised a global financial institution on a dispute with Chinese tax bureau regarding the tax treatment of company’s US$710 million capital gains.
Advised a global consumer brand listed on Hong Kong Stock Exchange and its Chinese subsidiaries on a transfer pricing audit related to intercompany loans.
Advised a leading global supplier of intelligent testing, instrumentation and assembly systems on the restructuring of its subsidiaries in Asia.
Advised DDW The Color House, a global privately held company specializing in natural color solutions for the food and beverage industry, on its sale to Givaudan, a global leader in fragrances and flavors.
Advised 3D Systems in acquiring Oqton, a leading software company in cash-and-stock deal worth $180 million.
Advised a Taiwan-based live social entertainment platform on tax issues in its global restructuring plan.
Advised a Sweden-based telecommunications and cloud communications company on tax planning and general corporate issues.
